{"id":246267,"date":"2026-03-19T11:44:59","date_gmt":"2026-03-19T11:44:59","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=246267"},"modified":"2026-03-19T11:44:59","modified_gmt":"2026-03-19T11:44:59","slug":"medicamentele-pentru-slabit-ar-putea-reduce-riscul-de-depresie-si-anxietate","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=246267","title":{"rendered":"Medicamentele pentru sl\u0103bit ar putea reduce riscul de depresie \u015fi anxietate"},"content":{"rendered":"<p>\nCercetarea, citat\u0103 de Euronews, a fost realizat\u0103 de exper\u0163i de la University of Eastern Finland, Karolinska Institutet \u015fi Griffith University. Aceasta a analizat datele a peste 95.000 de persoane diagnosticate cu depresie sau anxietate. Rezultatele arat\u0103 c\u0103 tratamentele pe baz\u0103 de semaglutid\u0103 sunt asociate cu un risc cu 42% mai mic de agravare a tulbur\u0103rilor mintale. De asemenea s-a constatat o reducere de 44% a riscului de depresie dar \u015fi o sc\u0103dere de 38% a riscului de anxietate. Medicamentul a mai fost corelat \u015fi cu un risc mai redus de consum problematic de substan\u0163e \u015fi de auto-v\u0103t\u0103mare.<\/p>\n<p>\nSubstan\u0163e precum semaglutida \u015fi liraglutida fac parte din clasa medicamentelor GLP-1, utilizate \u00een mod obi\u015fnuit pentru tratarea diabetului \u015fi obezit\u0103\u0163ii. Acestea imit\u0103 un hormon natural din organism care regleaz\u0103 apetitul \u015fi nivelul zah\u0103rului din s\u00e2nge, contribuind astfel la pierderea \u00een greutate \u015fi la controlul glicemiei.Speciali\u015ftii subliniaz\u0103 c\u0103 rela\u0163ia dintre s\u0103n\u0103tatea fizic\u0103 \u015fi cea mintal\u0103 este complex\u0103. Potrivit World Health Organization, aproximativ 1 din 6 persoane din Europa sufer\u0103 de o afec\u0163iune mintal\u0103. \u00cen acela\u015fi timp, depresia este aproape de dou\u0103 ori mai frecvent\u0103 la persoanele cu diabet, conform International Diabetes Federation. Rela\u0163ia func\u0163ioneaz\u0103 \u00een ambele sensuri: problemele psihice pot cre\u015fte riscul de diabet, iar diabetul poate agrava s\u0103n\u0103tatea mintal\u0103.<\/p>\n<p>\nAutorii studiului subliniaz\u0103 c\u0103 rezultatele nu demonstreaz\u0103 o rela\u0163ie direct\u0103 de cauzalitate. Nu este clar dac\u0103 \u00eembun\u0103t\u0103\u0163irea s\u0103n\u0103t\u0103\u0163ii mintale este determinat\u0103 direct de medicament, de pierderea \u00een greutate sau de al\u0163i factori. Totu\u015fi, concluziile ofer\u0103 un punct de plecare important pentru viitoare studii clinice care ar putea clarifica aceste mecanisme.<\/p>\n<p>\nDac\u0103 rezultatele vor fi confirmate, medicamentele GLP-1 ar putea deveni nu doar un instrument pentru controlul greut\u0103\u0163ii \u015fi al diabetului, ci \u015fi un sprijin important \u00een gestionarea s\u0103n\u0103t\u0103\u0163ii mintale. \u00centr-un context \u00een care tulbur\u0103rile psihice afecteaz\u0103 milioane de oameni, orice progres \u00een aceast\u0103 direc\u0163ie ar putea avea un impact semnificativ asupra s\u0103n\u0103t\u0103\u0163ii publice.<\/p>\n<p>\n&nbsp;<\/p>\n<p>\n&nbsp;<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un nou studiu publicat \u00een The Lancet Psychiatry sugereaz\u0103 c\u0103 medicamentele pentru sl\u0103bit pe baz\u0103 de semaglutid\u0103 ar putea avea beneficii nea\u015fteptate asupra s\u0103n\u0103t\u0103\u0163ii mintale, fiind asociate cu un risc mai sc\u0103zut de depresie, anxietate \u015fi comportamente de auto-v\u0103t\u0103mare. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[323,26600],"class_list":["post-246267","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-medicamente","tag-slabit"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/246267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=246267"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/246267\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=246267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=246267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=246267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}